In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol

BACKGROUND: The purpose of the study was to evaluate the applicability of (18)F-labelled amyloid imaging positron emission tomography (PET) agent [(18)F]flutemetamol to detect changes in brain beta-amyloid (Aβ) deposition in vivo in APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer's di...

Descripción completa

Detalles Bibliográficos
Autores principales: Snellman, Anniina, Rokka, Johanna, López-Picón, Francisco R, Eskola, Olli, Salmona, Mario, Forloni, Gianluigi, Scheinin, Mika, Solin, Olof, Rinne, Juha O, Haaparanta-Solin, Merja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412375/
https://www.ncbi.nlm.nih.gov/pubmed/25977876
http://dx.doi.org/10.1186/s13550-014-0037-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412375/
https://www.ncbi.nlm.nih.gov/pubmed/25977876
http://dx.doi.org/10.1186/s13550-014-0037-3

Ejemplares similares